The Rapid Initiation, Titration, and Transition from Intravenous to Oral Treprostinil in a Patient with Severe Pulmonary Arterial Hypertension
In patients who require urgent initiation of pulmonary arterial hypertension medications due to disease progression, it is customary to start intravenous prostacyclin therapy, typically during a hospital admission. If there are complicating factors or relative contraindications to intravenous and su...
Saved in:
| Main Authors: | James Benjamin Gleason, Justin Dolan, Pirouz Piran, Franck Farzad Rahaghi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Pulmonology |
| Online Access: | http://dx.doi.org/10.1155/2015/498981 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Inhaled Treprostinil in a Patient with Systemic Sclerosis-Associated Pulmonary Hypertension and Interstitial Lung Diseases Refractory to Conventional Intravenous Epoprostenol
by: Yuki Hida, et al.
Published: (2025-01-01) -
Acute myocardial infarction following inhaled treprostinil initiation
by: Bilal Alqam, et al.
Published: (2025-01-01) -
Systematic evaluation of subgroup analyses of inhaled treprostinil in pulmonary hypertension due to interstitial lung disease.
by: Pablo Martínez-Puig, et al.
Published: (2025-01-01) -
Cost-Effectiveness of Treprostinil Versus Epoprostenol in Patients with Pulmonary Arterial Hypertension: A Canadian Analysis
by: Thomas R Einarson, et al.
Published: (2005-01-01) -
Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population
by: Andrew E. Stine, et al.
Published: (2025-01-01)